Contemporary theories of cervical carcinogenesis: The virus, the host, and the stem cell

Modern Pathology

Volumn 13, Issue 3, 2000, Pages 243-251

  Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cervical neoplasm; CIN; Human papillomavirus

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CHROMOSOME 3P; CHROMOSOME 3Q; FEMALE; GENETIC MARKER; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALIGNANT TRANSFORMATION; MORPHOLOGY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

EID: 0034078397     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880045     Document Type: Article

References (57)

1. Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998;16:330-7.
2. Barasso R. HPV-related genital lesions in men. IARC Sci Publ 1992;119:85-92.
3. Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlacek T, et al. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 1985;317:639-41.
4. Taichman LB, Reilly SS, LaPorta RF. The role of keratinocyte differentiation in the expression of epitheliotropic viruses. J Invest Dermatol 1983;81:137S-40S.
5. Crum CP, Mitao M, Levine RU, Silverstein S. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol 1985;54:675-81.
6. Demeter LM, Stoler MH, Broker TR, Chow LT. Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum Pathol 1994;25:343-8.
7. Resnick M, Lester S, Tate JE, Sheets EE, Sparks C, Crum CP. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Hum Pathol 1996;27:234-9.
8. Quade B, Park J, Crum CP, Sun, DQ, Dutta A. Cyclin E expression and early cervical neoplasia. Mod Pathol 1998;11: 1238-46.
9. Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 1996;13:2737-41.
10. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J Virol 1991; 65:606-12.
11. Heselmeyer K, Schrock E, Manoir S, Biegen H, Shah K, Steinbeck R, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 1996;93:479-84.
12. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
13. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-84.
14. Smotkin D, Berek JS, Fu YS, Hacker NF, Major FJ, Wettstein FO. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 1986;68:241-4.
15. Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989;63:159-64.
16. McLachlin CM, Tate J, Zitz J, Sheets EE, Crum CP. Human papillomavirus type 18 and low grade squamous intraepithelial lesions of the cervix. Am J Pathol 1994;144:141-7.
17. Kadish AS, Hagan RJ, Ritter DB, Goldberg GL, Romney SL, Kanetsky PA, et al. Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum Pathol 1992;23:1262-9.
18. Hecht JL, Kadish AS, Jiang G, Burk RD. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 1995;60:369-76.
19. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58: 829-33.
20. Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991;15:28-32.
21. Lombard I, Vincent-Salomon A, Validire P, Zafrani B, de la Rochefordiere A, Clough K, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998;16:2613-9.
22. Reagan JW, Patten SF Jr. Dysplasia: a basic reaction to injury in the uterine cervix. Ann N Y Acad Sci 1962;97:662-82.
23. Richart RM. Cervical intraepithelial neoplasia. In: Sommers SC, editor. Pathology annual. New York: Appleton; 1973. p. 301-28.
24. Smedts F, Ramaekers F, Robben H, Pruszczynski M, van Muijen G, Lane B, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 1990;136:657-68.
25. Watt FM. Epidermal stem cells: markers, patterning, and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci 1998;353:831-7.
26. Jih DM, Lyle S, Elenitsas R, Elder DE, Cotsarelis G. A cellular marker for the human hair follicle bulge identifies trichoepitheliomas and a subset of basal cell carcinomas. Mod Pathol 1999;12:58A.
27. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-16.
28. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson R, et al. P63 is essential for maintaining proliferative capacity of ectoderm involved in limb, craniofacial, and epithelial development. Nature 1999;398:714-8.
29. Yang A, Yang YM, Sun D, Park JJ, Quade BJ, McKeon F, et al. P63: a p53 homologue that is a differentiation-specific marker in cervical squamous epithelium. Mod Pathol 1999; 12:178A.
30. Koss LG, Stewart F, Foote FW, Jordan MJ, Bader GM, Day E. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix: a long-term prospective study. Cancer 1963;16:1160-211.
31. Ward BE, Saleh AM, Williams JV, Crum CP. Papillary immature metaplasia of the cervix: a distinct subset of exophytic cervical condyloma associated with HPV-6/11 nucleic acids. Mod Pathol 1992;5:391-5.
32. Trivijitsilp P, Mosher R, Sheets EE, Sun D, Crum CP. Papillary immature metaplasia (immature condyloma) of the cervix: a clinicopathologic analysis and comparison with papillary squamous carcinoma. Hum Pathol 1998;29:641-8.
33. Buchwald C, Franzmann MB, Jacobsen GK, Lindeberg H. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope 1995;105:66-71.
34. Geng L, Connolly DC, Isacson C, Ronnett BM, Cho KR. Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol 1999;30:345-51.
35. Park JJ, Genest DR, Sun D, Crum CP. Atypical immature squamous proliferations of the cervix: reproducibility and viral (HPV) correlates. Hum Pathol 1999;30:1161-5.
36. Park JJ, Sun D, Crum CP. Squamo-mucinous intraepithelial (SMIL) and invasive lesions of the cervix: a distinct pathologic entity. Mod Pathol 1999;12:121A.
37. Nuovo GJ, Pedemonte BM. Human papillomavirus types and recurrent cervical warts. JAMA 1990;263:1223-6.
38. Rosenfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. J Pediatr 1992;121:307-311.
39. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
40. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53:919-23.
41. Javonovic A-D, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis" Mod Pathol 1995;8:408-12.
42. Crum CP, Cibas ES, Lee KR. Pathology of early cervical neoplasia. New York: Churchill Livingstone; 1997. p. 105-6, 122-3, 150.
43. Park J, Sun D, Genest DR, Trivijitsilp P, Suh I, Crum CP. Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses? Gynecol Oncol 1998;70:386-91.
44. Wilbur DC, Bonfiglio TA, Stoler MH. Continuity of human papillomavirus (HPV) type between neoplastic precursors and invasive cervical carcinoma. An in situ hybridization study. Am J Surg Pathol 1988;12:182-6.
45. Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix: the World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996;144:281-9.
46. Brainard JA, Hart WR. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 1998;22:965-75.
47. Grayson W, Taylor LF, Cooper K. Adenoid basal carcinoma of the uterine cervix: detection of integrated human papillomavirus in a rare tumor of putative "reserve cell" origin. Int J Gynecol Pathol 1997;16:307-12.
48. Cviko A, Briem B, Granter S, Pinto A, Yang A, Sheets E, et al. Adenoid basal carcinoma of the cervix: a unique model of morphologic progression favoring a "benign" multipotential stem cell phenotype case. Mod Pathol 2000;13:123A.
49. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
50. Sun D, Park J, Crum CP. P53 polymorphisms: do they really influence cervical cancer risk? Mod Pathol 1999;12:125A.
51. Wang T, Cviko A, Crum CP, Yang YC, McKeon F, Quade BJ. P63 as distinguishes squamous and non-squamous neoplasms of the cervix: an analysis of 350 cases. Mod Pathol 2000;13:134A.
52. Liao SY, Brewer C, Zavada J, Pastorek J, Pastorekova S, Manetta A, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598-609.
53. Kleter B, van Doom LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9.
54. Crum CP. Detecting every genital papillomavirus infection: what does it mean? Am J Pathol 1998;153:1667-71.
55. Ronnett BM, Manos M, Ransley JE, Fetterman J, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
56. Chua KL, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 1997;66:108-13.
57. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999;91:954-60.